ACL to buy Medlab Pathology in a $65 million deal

SYDNEY, AUSTRALIA: Australian Clinical Labs (ACL) today entered into a binding agreement to purchase Medlab Pathology, a leading Australian privately-owned independent pathology provider, based in NSW and QLD. The acquisition is subject to regulatory approval and completion of customary conditions precedent. The acquisition an will be funded by an upfront payment of $60m plus a…